Cargando…

HLA DR Genome Editing with TALENs in Human iPSCs Produced Immune-Tolerant Dendritic Cells

Although human induced pluripotent stem cells (iPSCs) can serve as a universal cell source for regenerative medicine, the use of iPSCs in clinical applications is limited by prohibitive costs and prolonged generation time. Moreover, allogeneic iPSC transplantation requires preclusion of mismatches b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Yoo-Wook, Ahn, Hyo-Suk, Lee, Jin-Woo, Yang, Han-Mo, Cho, Hyun-Jai, Kim, Seok Joong, Lee, Shin-Hyae, Yang, Heung-Mo, Jang, Hyun-Duk, Kim, Sung Joo, Kim, Hyo-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163544/ https://www.ncbi.nlm.nih.gov/pubmed/34093711 http://dx.doi.org/10.1155/2021/8873383

Ejemplares similares

Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs
por: Yang, Yi, et al.
Publicado: (2018)

Identification of cell-biologic mechanisms of coronary artery spasm and its ex vivo diagnosis using peripheral blood-derived iPSCs
por: Yang, Han-Mo, et al.
Publicado: (2023)

Microhomology-assisted scarless genome editing in human iPSCs
por: Kim, Shin-Il, et al.
Publicado: (2018)

Improved and Flexible HDR Editing by Targeting Introns in iPSCs
por: Fu, Juan, et al.
Publicado: (2022)

TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation
por: Yahata, Naoki, et al.
Publicado: (2017)

Elimination of Mutant mtDNA by an Optimized mpTALEN Restores Differentiation Capacities of Heteroplasmic MELAS-iPSCs
por: Yahata, Naoki, et al.
Publicado: (2020)

Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs
por: Kim, Eunhye, et al.
Publicado: (2016)

Applications of iPSCs in Cancer Research
por: Kim, Jean J
Publicado: (2015)

Dysregulated ECM remodeling proteins lead to aberrant osteogenesis of Costello syndrome iPSCs
por: Choi, Jong Bin, et al.
Publicado: (2021)

Author Correction: TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513 G>A mutation
por: Yahata, Naoki, et al.
Publicado: (2018)

Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014)

iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)

TALENs Facilitate Single-step Seamless SDF Correction of F508del CFTR in Airway Epithelial Submucosal Gland Cell-derived CF-iPSCs
por: Suzuki, Shingo, et al.
Publicado: (2016)

Differentiation and Establishment of Dental Epithelial-Like Stem Cells Derived from Human ESCs and iPSCs
por: Kim, Gee-Hye, et al.
Publicado: (2020)

Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering
por: Gähwiler, Eric K. N., et al.
Publicado: (2021)

Both TALENs and CRISPR/Cas9 directly target the HBB IVS2–654 (C > T) mutation in β-thalassemia-derived iPSCs
por: Xu, Peng, et al.
Publicado: (2015)

iPSCs in NK Cell Manufacturing and NKEV Development
por: Boyd-Gibbins, Nicholas, et al.
Publicado: (2022)

Efficient Precision Genome Editing in iPSCs via Genetic Co-targeting with Selection
por: Mitzelfelt, Katie A., et al.
Publicado: (2017)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages
por: Lipus, Alexandra, et al.
Publicado: (2020)

Mitochondria fingerprint longevity in iPSCs
por: Masotti, Andrea, et al.
Publicado: (2015)

Reducing genomic instability in iPSCs
por: Ruiz, Sergio, et al.
Publicado: (2015)

The Challenge of Bringing iPSCs to the Patient
por: Ortuño-Costela, María del Carmen, et al.
Publicado: (2019)

iPSCs in Modeling and Therapy of Osteoarthritis
por: Csobonyeiova, Maria, et al.
Publicado: (2021)

Plant genome editing with TALEN and CRISPR
por: Malzahn, Aimee, et al.
Publicado: (2017)

 Potential of Gene Editing and Induced Pluripotent Stem Cells (iPSCs) in Treatment of Retinal Diseases 
por: Chuang, Katherine, et al.
Publicado: (2017)

NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs
por: Ichise, Hiroshi, et al.
Publicado: (2017)

Bacterial Delivery of TALEN Proteins for Human Genome Editing
por: Jia, Jingyue, et al.
Publicado: (2014)

iPSCs: From Bench to Clinical Bed
por: Li, Yujing, et al.
Publicado: (2016)

Differentiation of human iPSCs into functional podocytes
por: Rauch, Caroline, et al.
Publicado: (2018)

TALEN-mediated editing of the Mouse Y Chromosome
por: Wang, Haoyi, et al.
Publicado: (2013)

Efficient TALEN‐mediated gene editing in wheat
por: Luo, Ming, et al.
Publicado: (2019)

High-Level Precise Knockin of iPSCs by Simultaneous Reprogramming and Genome Editing of Human Peripheral Blood Mononuclear Cells
por: Wen, Wei, et al.
Publicado: (2018)

Modeling Pathogenesis and Treatment of Familial Dysautonomia using Patient Specific iPSCs
por: Lee, Gabsang, et al.
Publicado: (2009)

Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCs
por: Sung, Jin Jea, et al.
Publicado: (2019)

Use of single guided Cas9 nickase to facilitate precise and efficient genome editing in human iPSCs
por: Li, Pan P., et al.
Publicado: (2021)

Functional genomics in stroke: current and future applications of iPSCs and gene editing to dissect the function of risk variants
por: Granata, Alessandra
Publicado: (2023)

Nanog-Independent Reprogramming to iPSCs with Canonical Factors
por: Carter, Ava C., et al.
Publicado: (2014)

Disease, iPSCs and a Quest for the Perfect Model
Publicado: (2016)

Clinical Therapy Using iPSCs: Hopes and Challenges
por: Lu, Xiao, et al.
Publicado: (2013)

The Potential of iPSCs for the Treatment of Premature Aging Disorders
por: Compagnucci, Claudia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6tc8otkclqovkebltibautdvol